sur BASTIDE (EPA:BLC)
Bastide Group Finalizes Sale of EXPERF to Sapio Group
On June 1, 2026, Bastide Group announced the completion of the sale of New Medical Concept, the holding company of the French EXPERF Group, to Sapio Group. This agreement was signed on May 21, 2026, and all necessary conditions were met by the end of May.
Vincent Bastide, CEO of Bastide Group, emphasized that the sale aligns with their strategic goals, allowing them to focus on more critical areas of their business while strengthening their financial structure. The transaction supports their pursuit of sustainable and profitable growth.
Mario Paterlini, CEO of Sapio Group, stated that acquiring EXPERF aligns with their strategy for sustainable growth in Europe, particularly in the healthcare sector. The acquisition is expected to bolster Sapio's presence in France significantly.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE